(Total Views: 670)
Posted On: 12/17/2024 2:37:13 PM
Post# of 155128
Yes, nicer to hear that Cytodyn has stirred the RECOVER stew that Plotinus had already thickened.
I've been trying to use that pun for at least a year and I can't say I managed it here. Like the one about our poster number 24 who can't get no respert, poor guy.
Back to RECOVER. This is not the first group of clinical trials they've conducted in search of something they can use against Long Covid. The first group of trials, as far as I can tell, yielded nothing at all that they could run with. So they need something like Leronlimab at least as much as Cytodyn needs them. They received $662 million in funds in 2024, and that's probably burning a hole in their group pocket.
I've been trying to use that pun for at least a year and I can't say I managed it here. Like the one about our poster number 24 who can't get no respert, poor guy.
Back to RECOVER. This is not the first group of clinical trials they've conducted in search of something they can use against Long Covid. The first group of trials, as far as I can tell, yielded nothing at all that they could run with. So they need something like Leronlimab at least as much as Cytodyn needs them. They received $662 million in funds in 2024, and that's probably burning a hole in their group pocket.
(15)
(0)
